Fiasp
Fiasp is a rapid-acting insulin analog used to improve blood sugar control in adults and children with diabetes mellitus. It is a formulation of insulin aspart that includes additional excipients to accelerate its absorption and onset of action.
Composition[edit | edit source]
Fiasp contains the active ingredient insulin aspart, which is a rapid-acting human insulin analog. The formulation also includes nicotinamide (vitamin B3) to increase the speed of absorption, and arginine, an amino acid, to stabilize the insulin molecule.
Mechanism of Action[edit | edit source]
Fiasp works by mimicking the body's natural insulin response to meals. It helps to lower blood glucose levels by facilitating the uptake of glucose into cells, particularly in the liver, muscle, and fat tissue. This rapid-acting insulin analog begins to work within minutes of injection, making it suitable for use at mealtime.
Indications[edit | edit source]
Fiasp is indicated for the treatment of type 1 diabetes mellitus and type 2 diabetes mellitus in adults and children. It is typically administered subcutaneously before meals or within 20 minutes after starting a meal.
Administration[edit | edit source]
Fiasp is available in multiple forms, including:
- Vials
- Prefilled pens
- Cartridges for use in insulin pumps
The dosage and timing of Fiasp administration should be individualized based on the patient's needs, blood glucose monitoring results, and glycemic control goals.
Side Effects[edit | edit source]
Common side effects of Fiasp include:
- Hypoglycemia
- Injection site reactions
- Allergic reactions
- Weight gain
Patients should be monitored for signs of hypoglycemia and other adverse effects, and adjustments to the dosage may be necessary.
Storage[edit | edit source]
Fiasp should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F) until the expiration date. Once in use, it can be kept at room temperature (below 30°C or 86°F) for up to 28 days.
Related Pages[edit | edit source]
- Insulin
- Diabetes mellitus
- Type 1 diabetes mellitus
- Type 2 diabetes mellitus
- Hypoglycemia
- Insulin aspart
| Diabetes Drug Stub | |
|---|---|
| |
| This article about a diabetes drug is a stub. You can help WikiMD by expanding it. | |
| Related topics | Diabetes mellitus · Insulin · Hypoglycemia · Hyperglycemia |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
